ClinicalTrialsFinder
RecruitingNot ApplicableNCT06492980

A Triple-branched Stent Graft for Aute Debakey Type I Dissection Surgery

Safety and Effectiveness of a Triple-branched Stent Graft for Arch Repair During Open Aute Debakey Type I Dissection Surgery - a Randomized Controlled Multicenter Clinical Trial

Sponsor

Fujian Medical University

Enrollment

150 participants

Start Date

Oct 27, 2023

Study Type

INTERVENTIONAL

Conditions

Acute Aortic Dissection

Summary

Prospective, multicenter, randomized controlled clinical trial plan to evaluate the effectiveness and safety of intraoperative stent system in the treatment of acute type I aortic dissection

Eligibility

Min Age: 20 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called triple-branched stent graft for people with acute aortic dissection. The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREtriple-branched stent graft

a triple-branched stent graft for aortic arch repairement during surgery

Locations(1)

Department of Cardiovascular Surgery

Fuzhou, Fujian, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06492980

Related Trials

Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA

NCT0708957621 locations

Genetic Architecture of Acute Aortic Syndromes and Aortic Aneurysm.

NCT063536071 location